Artivion, Inc. (AORT) stock
AORTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 8/3023% above fair value
$19.40−0.70 (-3.48%)
Close on Nov 12, 2026Market cap $945.87MP/E –Yield –
Artivion ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Artivion's ebitda for the twelve months ending Sep 30, 2026 was $37.24M, down 23.6% year over year. For fiscal 2025 it was $56.20M, down 10.9% from the year before. Over ten years it grew 17.5% a year on average. The highest annual figure on record is $63.08M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $56.20M | -10.9% |
| FY2024 | Dec 31, 2024 | $63.08M | +118.9% |
| FY2023 | Dec 31, 2023 | $28.82M | +0.6% |
| FY2022 | Dec 31, 2022 | $28.64M | -10.8% |
| FY2021 | Dec 31, 2021 | $32.09M | +38.6% |
| FY2020 | Dec 31, 2020 | $23.15M | -34.5% |
| FY2019 | Dec 31, 2019 | $35.36M | +29.0% |
| FY2018 | Dec 31, 2018 | $27.41M | +54.7% |
| FY2017 | Dec 31, 2017 | $17.72M | -41.3% |
| FY2016 | Dec 31, 2016 | $30.20M | +169.3% |
| FY2015 | Dec 31, 2015 | $11.22M | -24.5% |
| FY2014 | Dec 31, 2014 | $14.87M | -24.4% |
| FY2013 | Dec 31, 2013 | $19.66M | +7.8% |
| FY2012 | Dec 31, 2012 | $18.25M | +9.9% |
| FY2011 | Dec 31, 2011 | $16.60M | +20.3% |
| FY2010 | Dec 31, 2010 | $13.81M | -26.4% |
| FY2009 | Dec 31, 2009 | $18.76M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $10.29M | -43.6% |
| Q2 FY2026 | Jun 30, 2026 | -$1.62M | -111.6% |
| Q1 FY2026 | Mar 31, 2026 | $12.13M | +59.8% |
| Q4 FY2025 | Dec 31, 2025 | $16.44M | +83.4% |
| Q3 FY2025 | Sep 30, 2025 | $18.25M | +73.9% |
| Q2 FY2025 | Jun 30, 2025 | $13.92M | +12.3% |
| Q1 FY2025 | Mar 31, 2025 | $7.59M | -75.7% |
| Q4 FY2024 | Dec 31, 2024 | $8.96M | -0.3% |
| Q3 FY2024 | Sep 30, 2024 | $10.50M | +132.5% |
| Q2 FY2024 | Jun 30, 2024 | $12.40M | -7.8% |
| Q1 FY2024 | Mar 31, 2024 | $31.22M | +1566.8% |
| Q4 FY2023 | Dec 31, 2023 | $8.99M | -5.9% |
| Q3 FY2023 | Sep 30, 2023 | $4.52M | +219.5% |
| Q2 FY2023 | Jun 30, 2023 | $13.44M | +32.3% |
| Q1 FY2023 | Mar 31, 2023 | $1.87M | -75.1% |
| Q4 FY2022 | Dec 31, 2022 | $9.56M | – |
| Q3 FY2022 | Sep 30, 2022 | $1.41M | -93.2% |
| Q2 FY2022 | Jun 30, 2022 | $10.16M | +38.8% |
| Q1 FY2022 | Mar 31, 2022 | $7.52M | +0.9% |
| Q4 FY2021 | Dec 31, 2021 | -$3.37M | -143.2% |
| Q3 FY2021 | Sep 30, 2021 | $20.70M | +134.9% |
| Q2 FY2021 | Jun 30, 2021 | $7.32M | +159.1% |
| Q1 FY2021 | Mar 31, 2021 | $7.45M | +100.8% |
| Q4 FY2020 | Dec 31, 2020 | $7.81M | -10.2% |
| Q3 FY2020 | Sep 30, 2020 | $8.81M | -4.6% |
| Q2 FY2020 | Jun 30, 2020 | $2.82M | -74.0% |
| Q1 FY2020 | Mar 31, 2020 | $3.71M | -43.4% |
| Q4 FY2019 | Dec 31, 2019 | $8.69M | +20.1% |
| Q3 FY2019 | Sep 30, 2019 | $9.23M | +0.9% |
| Q2 FY2019 | Jun 30, 2019 | $10.88M | +7.4% |
| Q1 FY2019 | Mar 31, 2019 | $6.56M | +640.0% |
| Q4 FY2018 | Dec 31, 2018 | $7.24M | +152.5% |
| Q3 FY2018 | Sep 30, 2018 | $9.15M | +189.5% |
| Q2 FY2018 | Jun 30, 2018 | $10.13M | +45.4% |
| Q1 FY2018 | Mar 31, 2018 | $886.00K | -81.2% |
| Q4 FY2017 | Dec 31, 2017 | $2.87M | -60.4% |
| Q3 FY2017 | Sep 30, 2017 | $3.16M | – |
| Q2 FY2017 | Jun 30, 2017 | $6.97M | – |
| Q1 FY2017 | Mar 31, 2017 | $4.72M | – |
| Q4 FY2016 | Dec 31, 2016 | $7.24M | – |
See a number that looks wrong?